CH
BLCM

CVI Holdings’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

CVI Holdings’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-16,874
Closed -$177K – 50
2019
Q3 		$177K Buy
+16,874
New +$221K 0.4% 19

Other funds holding BLCM

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CVI Holdings's BLCM Position: Q4 2019 in Review

CVI Holdings sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q4 2019, closing a stake of 16,874 shares — an estimated $177K sold.

CVI Holdings first reported a position in BLCM in Q3 2019 and held it in 1 quarter. The position peaked at $177K in Q3 2019. 51 funds tracked by Wall St. Rank hold BLCM as of Q4 2019.

  • CVI Holdings reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q4 2019 after selling out during the quarter.
  • CVI Holdings sold 16,874 Bellicum Pharmaceuticals, Inc. shares in Q4 2019, an estimated $177K.
  • CVI Holdings first reported a position in Bellicum Pharmaceuticals, Inc. in Q3 2019 and held it in 1 quarter.
  • CVI Holdings's Bellicum Pharmaceuticals, Inc. position peaked at $177K in Q3 2019.
  • 51 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q4 2019.

Based on CVI Holdings's 13F filing for Q4 2019, filed 14 Feb 2020.